Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    arry-502
Show Display Options
Rank Status Study
1 Completed A Safety Study of ARRY-502 in Healthy Subjects
Condition: Healthy
Interventions: Drug: ARRY-502;   Drug: Placebo
2 Completed A Study of ARRY-502 in Patients With Persistent Asthma
Condition: Asthma
Interventions: Drug: ARRY-502, CRTh2 antagonist; oral;   Drug: Placebo; oral

Indicates status has not been verified in more than two years